کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3055805 1186539 2011 12 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
پیش نمایش صفحه اول مقاله
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
چکیده انگلیسی

Serotonin 1A receptor (5-HT1AR) agonists reduce both l-DOPA- and D1 receptor (D1R) agonist-mediated dyskinesia, but their anti-dyskinetic mechanism of action is not fully understood. Given that 5-HT1AR stimulation reduces glutamatergic neurotransmission in the dopamine-depleted striatum, 5-HT1AR agonists may diminish dyskinesia in part through modulation of pro-dyskinetic striatal glutamate levels. To test this, rats with unilateral medial forebrain bundle dopamine or sham lesions were primed with l-DOPA (12 mg/kg + benserazide, 15 mg/kg, sc) or the D1R agonist SKF81297 (0.8 mg/kg, sc) until abnormal involuntary movements (AIMs) stabilized. On subsequent test days, rats were treated with vehicle or the 5-HT1AR agonist ± 8-OH-DPAT (1.0 mg/kg, sc), followed by l-DOPA or SKF81297, or intrastriatal ± 8-OH-DPAT (7.5 or 15 mM), followed by l-DOPA. In some cases, the 5-HT1AR antagonist WAY100635 was employed to determine receptor-specific effects. In vivo microdialysis was used to collect striatal samples for analysis of extracellular glutamate levels during AIMs assessment. Systemic and striatal ± 8-OH-DPAT attenuated l-DOPA-induced dyskinesia and striatal glutamate efflux while WAY100635 reversed ± 8-OH-DPAT's effects. Interestingly, systemic ± 8-OH-DPAT diminished D1R-mediated AIMs without affecting glutamate. These findings indicate a novel anti-dyskinetic mechanism of action for 5-HT1AR agonists with implications for the improved treatment of Parkinson's disease.

Research Highlights
► l-DOPA treatment augmented glutamate in the DA-depleted striatum.
► D1R agonist administration did not modify striatal glutamate levels.
► 5-HT1AR agonism diminished l-DOPA-induced striatal glutamate efflux and dyskinesia.
► 5-HT1AR agonism reduced D1R-mediated dyskinesia without affecting striatal glutamate.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Experimental Neurology - Volume 229, Issue 2, June 2011, Pages 288–299
نویسندگان
, , , , , , ,